Effectiveness of Mobiderm Autofit in the Intensive Phase of Breast Cancer-Related Lymphedema Treatment: A Case Series
Lymphatic Research and Biology · 2023
DOI: 10.1089/lrb.2022.0079 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lymphatic Research and Biology, 2023. Verfasst von Sławomir Mazur und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation, Curie National Research Institute of Oncology (MSCNRIO), Warsaw, Poland. Hauptthemen laut MEDLINE: Breast Neoplasms, Breast Cancer Lymphedema, Lymphedema. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rehabilitation, Curie National Research Institute of Oncology (MSCNRIO), Warsaw, Poland.
Zitieren
APA
Mazur, S., Szczęśniak, D., & Tchórzewska-Korba, H. (2023). Effectiveness of Mobiderm Autofit in the Intensive Phase of Breast Cancer-Related Lymphedema Treatment: A Case Series. Lymphatic Research and Biology. https://doi.org/10.1089/lrb.2022.0079
Vancouver
Mazur S, Szczęśniak D, Tchórzewska-Korba H. Effectiveness of Mobiderm Autofit in the Intensive Phase of Breast Cancer-Related Lymphedema Treatment: A Case Series. Lymphatic Research and Biology. 2023. doi:10.1089/lrb.2022.0079
BibTeX
@article{Mazur2023,
author = {Mazur, Sławomir and Szczęśniak, Dorota and Tchórzewska-Korba, Hanna},
title = {Effectiveness of Mobiderm Autofit in the Intensive Phase of Breast Cancer-Related Lymphedema Treatment: A Case Series},
journal = {Lymphatic Research and Biology},
year = {2023},
doi = {10.1089/lrb.2022.0079}
}
EUVIMED